DEF 14A: Quantum-Si Seeks Stockholder Approval for Key Charter Amendments at 2024 Annual Meeting

Quantum-Si Incorporated is holding its 2024 annual meeting of stockholders virtually on May 15, 2024, to vote on the election of directors, ratification of the company's auditor, executive compensation, and proposed amendments to the company's certificate of incorporation.

Summary

• Quantum-Si Incorporated is soliciting proxies for its 2024 annual meeting of stockholders to be held virtually on May 15, 2024.
• Stockholders will vote on several key proposals, including the election of nine directors, ratification of Deloitte & Touche LLP as the independent auditor, and approval of executive compensation.
• The company is also seeking approval for amendments to its certificate of incorporation to remove the cap on the number of directors and to add a sunset provision for the automatic conversion of Class B common stock to Class A common stock on June 10, 2028.
• The board of directors recommends voting in favor of all proposals.
• The record date for determining stockholders eligible to vote is March 11, 2024.
• The company intends to begin sending the Notice of Internet Availability of Proxy Materials on or about April 3, 2024.
• The meeting will be held virtually at 12:00 p.m. Eastern Time on May 15, 2024.
• Stockholders can attend, vote, and submit questions during the virtual meeting.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, which is generally neutral in tone. The proposals are routine, but the potential impact of the certificate of incorporation amendments warrants careful consideration.

Positives

• The proposed sunset amendment to the Certificate of Incorporation to add a provision with respect to the automatic conversion of our Class B common stock effective June 10, 2028, which is seven years from the date of the closing of our Business Combination, to create alignment between economic interests and voting rights, reduce the concentration of our voting power, and incentivize stockholders to vote.
• The proposed amendments to the certificate of incorporation would provide the board of directors greater flexibility to use its discretion to establish an appropriate number of directors from time-to-time based on the needs of the Company and the availability of qualified candidates.

Negatives

• Jonathan M. Rothberg, Ph.D., beneficially owns 100% of the Class B common stock and controls a majority of the voting power of all of our outstanding capital stock (79.97% as of March 1, 2024).
• Dr. Rothberg is able to control matters submitted to our stockholders for approval, including the election of directors, amendments of our organizational documents and any merger, consolidation, sale of all or substantially all of our assets or other major corporate transactions.
• Dr. Rothberg, as controlling shareholder, may have interests that differ from other stockholders and may vote in a way with which other stockholders disagree and which may be adverse to the interests of other stockholders.
• This concentrated control may have the effect of delaying, preventing or deterring a change in control of the Company, could deprive our stockholders of an opportunity to receive a premium for their capital stock as part of a sale of the Company, and might ultimately affect the market price of shares of our Class A common stock.
• As a result, conflicts of interest may arise among Dr. Rothberg, on the one hand, and the Company and holders of our Class A common stock on the other hand.
• If the holders of our Class A common stock are dissatisfied with the performance of our board of directors, they have no ability to remove any of our directors, with or without cause.

Risks

• The concentrated voting power of Dr. Rothberg could lead to decisions that are not in the best interests of minority shareholders.
• Failure to ratify the appointment of Deloitte & Touche LLP as the independent auditor could require the audit committee to reconsider its selection.
• The advisory vote on executive compensation is non-binding, so the compensation committee and board are not obligated to act on the results.
• The proposed amendments to the certificate of incorporation require stockholder approval, and failure to obtain such approval could limit the company's flexibility in the future.

Future Outlook

The company is seeking stockholder approval for amendments to its certificate of incorporation that would provide greater flexibility in board composition and capital structure.

Management Comments

• Jeffrey Hawkins, President & Chief Executive Officer, thanks stockholders for their continued support and encourages them to vote promptly.

Industry Context

This proxy statement is a standard part of corporate governance for publicly traded companies, ensuring stockholders have the information needed to make informed decisions about the company's direction.

Comparison to Industry Standards

• The proposals outlined in the proxy statement, such as director elections, auditor ratification, and executive compensation approval, are standard practices for publicly traded companies.
• The proposed amendments to the certificate of incorporation, including removing the cap on the number of directors and adding a sunset provision for the dual-class stock structure, are strategic decisions that can impact the company's governance and attractiveness to investors.
• Comparable companies with dual-class stock structures, such as Alphabet (GOOGL) and Meta Platforms (META), have faced similar discussions regarding the long-term impact of concentrated voting power.
• The level of executive compensation is often compared to peer companies in the biotechnology or life sciences industries to ensure competitiveness and alignment with performance.

Corporate Governance

Related Party Transactions

• The company has lease arrangements with entities related to Jonathan M. Rothberg, Ph.D., the Chairman of the board of directors.
• The company has a Master Services Agreement with 4C, an entity controlled by the Rothberg family, for various services.
• The company has a Technology and Services Exchange Agreement with other companies controlled by the Rothberg family.
• The company has license agreements with other companies controlled by the Rothberg family.
• The company had a Binders Collaboration and Protein Engineering Collaboration with Protein Evolution, Inc., where Dr. Rothberg serves as Chairman of the board of directors.

Stakeholder Impact

• Approval of the proposed amendments to the certificate of incorporation could impact the voting rights and influence of different classes of stockholders.
• The election of directors will determine the composition of the board and its oversight of the company's management and strategy.
• The advisory vote on executive compensation provides stockholders with an opportunity to express their views on the company's pay practices.
• The ratification of the independent auditor ensures the integrity of the company's financial reporting.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The company will hold its annual meeting on May 15, 2024, to discuss and vote on the proposals.
• The company will announce the voting results in a Current Report on Form 8-K.

Key Dates

Keywords

proxy statement, annual meeting, stockholders, directors, executive compensation, certificate of incorporation, Deloitte & Touche LLP, Class B common stock, Class A common stock, voting rights, corporate governance